This compound is relatively new having had its first CT in the year 2012.
Adipotide is a peptide that is designed to antagonize the two receptors ANXA2 and prohibitin.
These receptors play a big role in the blood vessels supplying white fat cells, antagonizing them leads to apoptosis thus leading to fat loss.
Study done on rhesus monkeys
Both groups treated with Adipotide showed significant fat loss in comparison to the control groups.
Adipotide selectively burns visceral fat first before subcutaneous fat.
It also appears to be only effective for obese individuals, no drastic changes were noted for lean animals.
Use case
- At a high bf% wanting to cut down fast
- Alternative to DNP in terms of effectivity
- Wanting to kill fat cells permanently
Benefits
- Improvement in insulin sensitivity
- Obviously fat loss
- Permanently kills fat cells unlike any other fat burners
- No rebound effect
- Quick results
- Selectivity
Risks
- Renal toxicity (Reversible after cessation of treatment)
- No real data on humans
- High dosages needed (0.5–10 mg/kg/day for animals)
- Inflammation due to tissue remodelling (Use an antioxidant while on-cycle)